Efficacy of Tixagevimab and Cilgavimab Against SARS-CoV-2 Infections in Patients with Inborn Errors of Immunity

Detalles Bibliográficos
Autores principales: Johnson, Sarah, McDonnell, John C., Fernandez, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978277/
https://www.ncbi.nlm.nih.gov/pubmed/36862321
http://dx.doi.org/10.1007/s10875-023-01457-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978277/
https://www.ncbi.nlm.nih.gov/pubmed/36862321
http://dx.doi.org/10.1007/s10875-023-01457-z

Ejemplares similares